Farms.com Home   News

When insects take care of the pest control for us

In this week’s podcast, we feature Dr. George Heimpel, University of Minnesota Professor of Entomology, and members from his lab, Dr. Carl Stenoien and Jonathan Dregni.
 
 
A parasitoid wasp (Aphelinus glycinis) laying an egg in a soybean aphid.
 
Heimpel discussed how biological control, or beneficial species suppressing other pests, fits within IPM through reducing the likelihood of pest populations reaching damaging levels. In cases of invasive species, insects that feed on the invasive pest in their native range may be imported in after heavy regulatory scrutiny and can turn a common invasive pest into only a sporadic pest.
 
 
Aphid “mummies” are the husk leftover as an aphid has been consumed by a parasitoid larva. Different parasitoid species can leave behind different colored mummies (e.g., left brown mummy: Lysiphlebus testaceipes, right black mummy: Aphelinus certus)
 
Multiple species of parasitic wasps that have been considered for import against soybean aphid were discussed. These are small wasps that cannot sting people, but instead lay eggs inside the host insect. When the eggs hatch, the larvae consume the aphids. One species, Aphelinus certus, has been found parasitizing soybean aphid across the state in recent years, and may be significantly suppressing soybean aphid populations in some areas.
 
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.